SElf-SAMpling in Cervical Cancer Screening; SESAM Study
NCT02945891 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 310
Last updated 2017-04-06
Summary
Study aims to support development of evidence based health care in Norway through evaluating recently proposed technological improvements in cervical cancer control before their routine use. SESAM II study evaluates the accuracy of vaginal self-sampling for high risk human papillomavirus (hrHPV) testing compared with a physician-taken sample.
Conditions
Interventions
- DEVICE
-
HPV testing of Evalyn®Brush, FloqSwab and Colli-Pee specimens
Each woman use the self-sampling devices in an advised order the day before they go to the hospital. There will be change of sampling order with every patient so that 50% of women will use Evalyn®Brush (Rovers Medical Devices, Oss, The Netherlands) first and 50% a FloqSwab (Coban Flock Technologies, Italy) first. In addition women are asked to provide a first void urine sample using a Colli-PeeTM (Novosanis, Belgium) on the same morning as the hospital visit. At the hospital clinician will take an additional specimen for which the performance of different self-sampling devices will be compared to.
Sponsors & Collaborators
-
Ostfold Hospital Trust
collaborator OTHER -
Oslo University Hospital
lead OTHER
Principal Investigators
-
Giske Ursin, MD, Prof · Oslo University Hospital, Cancer Registry of Norway
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2017-12-31
- Completion
- 2018-12-31
Countries
- Norway
Study Locations
More Related Trials
-
Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia
NCT04411849 ·Status: COMPLETED ·Phase: NA
-
Self- Sampling in Cervical Cancer Routine Screening
NCT06931184 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Self-sampling for Non-attenders to Cervical Cancer Screening
NCT04226313 ·Status: RECRUITING ·Phase: NA
-
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
NCT07244315 ·Status: COMPLETED
-
HPV Self-sampling in the General Population
NCT06749847 ·Status: RECRUITING ·Phase: NA
-
Vaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-mediated Inflammatory Diseases
NCT06302725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Self-Sampling for Human Papillomavirus (HPV) at Well Women Appointments
NCT04591977 ·Status: TERMINATED ·Phase: NA
-
HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs
NCT04133610 ·Status: COMPLETED ·Phase: NA
-
HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme
NCT06371118 ·Status: RECRUITING ·Phase: NA
-
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01588301 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
HPV Test of Urine and Self Collected Vaginal Samples for Cervical Cancer Screening Study
NCT03409471 ·Status: UNKNOWN
-
Predictors of CIN Study Series 5.0:Stability Study in Vaginal Self-samples
NCT02622997 ·Status: COMPLETED ·Phase: NA
-
HPV in Sentinel Lymph Nodes of Cervical Cancer Patients
NCT03749707 ·Status: COMPLETED ·Phase: NA
-
The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples
NCT04423679 ·Status: COMPLETED
-
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
NCT05774561 ·Status: RECRUITING
-
HPV Self-Test Intervention in Ohio Appalachia
NCT02460237 ·Status: COMPLETED ·Phase: NA
-
Vaginal Self-sampling and Human Papillomavirus Testing in Unscreened Women
NCT02255084 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Strategies Involving Self-sampling to Reach Women Not Participating in Regular Cervical Cancer Screening
NCT05243888 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Acceptability of HPV-self Sampling
NCT03137563 ·Status: COMPLETED
-
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
NCT04679675 ·Status: COMPLETED ·Phase: NA
-
Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65
NCT05414929 ·Status: UNKNOWN ·Phase: NA
-
A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.
NCT02976987 ·Status: COMPLETED ·Phase: PHASE2
-
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01014026 ·Status: COMPLETED ·Phase: PHASE3
-
St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic
NCT05092022 ·Status: RECRUITING ·Phase: NA
-
Self-sampling for Non-participants in an Organised Cervical Cancer Screening Programme
NCT02680262 ·Status: COMPLETED ·Phase: NA